Pamrevlumab Active Not Recruiting Phase 3 Trials for Pancreatic Metastatic Cancer / Pancreatic Adenocarcinoma Metastatic Treatment

IndicationsStatusPurposePhase
Active Not RecruitingTreatment3
clinicaltrials.gov IdentifierTitleDrugs
NCT04229004A Multi-center Trial to Evaluate Multiple Regimens in Metastatic Pancreatic Cancer